Abstract

An understanding of factors influencing implementation is essential to realise the benefits of population-based reproductive genetic carrier screening programs. The aim of this study was to synthesise data collected during the Australian Reproductive Genetic Carrier Screening Project (Mackenzie’s Mission) to track how priorities shifted over time and identify important factors during scaling-up and for sustainment. We used a multi-method qualitative approach to integrate longitudinal project data collected from 10 project committees with 16 semi-structured interviews conducted with study team members. Both datasets were analysed using the Consolidated Framework for Implementation Research (CFIR) to identify constructs of interest within early, mid-point, and future implementation phases. Several CFIR constructs were present across implementation. The complexity of implementation presented challenges that were overcome through a quality-designed and packaged product, formal and informal networks and communication, and access to knowledge and information. Addressing the diverse consumer needs through resources and increasing community and non-genetic speciality engagement remained a priority throughout and for future sustainment. Going forward, further addressing program complexities and securing funding were emphasised. By applying an implementation framework, findings from this study may be useful for future effort towards building and/or sustaining reproductive genetic carrier screening programs.

Details

Title
Scaling-up and future sustainability of a national reproductive genetic carrier screening program
Author
Fehlberg, Zoe 1   VIAFID ORCID Logo  ; Best, Stephanie 2   VIAFID ORCID Logo  ; Long, Janet C. 3 ; Theodorou, Tahlia 3 ; Pope, Catherine 4 ; Hibbert, Peter 5 ; Williams, Sharon 6 ; Freeman, Lucinda 7 ; Righetti, Sarah 8 ; Archibald, Alison D. 9 ; Braithwaite, Jeffrey 10 

 Macquarie University, Australian Institute of Heath Innovation, Sydney, Australia (GRID:grid.1004.5) (ISNI:0000 0001 2158 5405); Australian Genomics Health Alliance, Melbourne, Australia (GRID:grid.1004.5); Murdoch Children’s Research Institute, Melbourne, Australia (GRID:grid.1058.c) (ISNI:0000 0000 9442 535X) 
 Macquarie University, Australian Institute of Heath Innovation, Sydney, Australia (GRID:grid.1004.5) (ISNI:0000 0001 2158 5405); Australian Genomics Health Alliance, Melbourne, Australia (GRID:grid.1004.5); Murdoch Children’s Research Institute, Melbourne, Australia (GRID:grid.1058.c) (ISNI:0000 0000 9442 535X); Peter MacCallum Cancer Centre, Department of Health Services Research, Melbourne, Australia (GRID:grid.1055.1) (ISNI:0000000403978434); Victorian Comprehensive Cancer Centre, Melbourne, Australia (GRID:grid.431578.c) (ISNI:0000 0004 5939 3689); University of Melbourne, Sir Peter MacCallum Cancer Centre Dept of Oncology, Melbourne, Australia (GRID:grid.1008.9) (ISNI:0000 0001 2179 088X) 
 Macquarie University, Australian Institute of Heath Innovation, Sydney, Australia (GRID:grid.1004.5) (ISNI:0000 0001 2158 5405) 
 University of Oxford, Nuffield Department of Primary Care Health Sciences, Oxford, UK (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948) 
 Macquarie University, Australian Institute of Heath Innovation, Sydney, Australia (GRID:grid.1004.5) (ISNI:0000 0001 2158 5405); University of South Australia, IIMPACT in Health, Allied Health and Human Performance, Adelaide, Australia (GRID:grid.1026.5) (ISNI:0000 0000 8994 5086) 
 Swansea University, School of Health & Social Care, Swansea, UK (GRID:grid.4827.9) (ISNI:0000 0001 0658 8800) 
 University of New South Wales, School of Women’s and Children’s Health, Sydney, Australia (GRID:grid.1005.4) (ISNI:0000 0004 4902 0432); University of Technology Sydney, Graduate School of Health, Sydney, Australia (GRID:grid.117476.2) (ISNI:0000 0004 1936 7611) 
 University of New South Wales, School of Women’s and Children’s Health, Sydney, Australia (GRID:grid.1005.4) (ISNI:0000 0004 4902 0432); Sydney Children’s Hospital Network, Centre for Clinical Genetics, Sydney, Australia (GRID:grid.430417.5) (ISNI:0000 0004 0640 6474) 
 Murdoch Children’s Research Institute, Victorian Clinical Genetics Services, Melbourne, Australia (GRID:grid.1058.c) (ISNI:0000 0000 9442 535X); The University of Melbourne, Department of Paediatrics, Melbourne, Australia (GRID:grid.1008.9) (ISNI:0000 0001 2179 088X) 
10  Macquarie University, Australian Institute of Heath Innovation, Sydney, Australia (GRID:grid.1004.5) (ISNI:0000 0001 2158 5405); Australian Genomics Health Alliance, Melbourne, Australia (GRID:grid.1004.5) 
Pages
18
Publication year
2023
Publication date
2023
Publisher
Nature Publishing Group
e-ISSN
20567944
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2843968673
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.